PT99618A - Processo para a realizacao de um ensaio de ligacao a recptores celulares isentode celulas e de identificacao caracterizacao e deteccao de agentes biologicos por meio desse ensaio - Google Patents

Processo para a realizacao de um ensaio de ligacao a recptores celulares isentode celulas e de identificacao caracterizacao e deteccao de agentes biologicos por meio desse ensaio

Info

Publication number
PT99618A
PT99618A PT99618A PT9961891A PT99618A PT 99618 A PT99618 A PT 99618A PT 99618 A PT99618 A PT 99618A PT 9961891 A PT9961891 A PT 9961891A PT 99618 A PT99618 A PT 99618A
Authority
PT
Portugal
Prior art keywords
test
ligacation
isentode
cells
carrying
Prior art date
Application number
PT99618A
Other languages
English (en)
Other versions
PT99618B (pt
Inventor
Gerd Zettlmeissl
Leander Lauffer
Patricia Oquendo
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT99618A publication Critical patent/PT99618A/pt
Publication of PT99618B publication Critical patent/PT99618B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7153—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT99618A 1990-11-28 1991-11-27 Processo para a realizacao de um ensaio de ligacao a recptores celulares isentode celulas e de identificacao caracterizacao e deteccao de agentes biologicos por meio desse ensaio PT99618B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4037837A DE4037837A1 (de) 1990-11-28 1990-11-28 Zellfreie rezeptorbindungsteste, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
PT99618A true PT99618A (pt) 1992-10-30
PT99618B PT99618B (pt) 1999-05-31

Family

ID=6419080

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99618A PT99618B (pt) 1990-11-28 1991-11-27 Processo para a realizacao de um ensaio de ligacao a recptores celulares isentode celulas e de identificacao caracterizacao e deteccao de agentes biologicos por meio desse ensaio

Country Status (13)

Country Link
US (1) US5639597A (pt)
EP (1) EP0488170B1 (pt)
JP (1) JP3164865B2 (pt)
KR (1) KR100210183B1 (pt)
AT (1) ATE140084T1 (pt)
AU (1) AU660950B2 (pt)
CA (1) CA2056279C (pt)
DE (2) DE4037837A1 (pt)
DK (1) DK0488170T3 (pt)
ES (1) ES2090211T3 (pt)
GR (1) GR3020611T3 (pt)
IE (1) IE75724B1 (pt)
PT (1) PT99618B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541610B1 (en) 1989-09-05 2003-04-01 Immunex Corporation Fusion proteins comprising tumor necrosis factor receptor
EP0939121B2 (de) 1989-09-12 2007-12-26 AHP Manufacturing B.V. TFN-bindende Proteine
US20030064480A1 (en) * 1990-06-28 2003-04-03 Leander Lauffer Fusion proteins with immunoglobulin portions, the preparation and use thereof
DE4322330A1 (de) * 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
ATE242322T1 (de) * 1992-03-30 2003-06-15 Immunex Corp Fusionsprotein , das zwei rezeptoren des tumornekrose-faktors enthält
US6107059A (en) * 1992-04-29 2000-08-22 Affymax Technologies N.V. Peptide library and screening method
DE4228839A1 (de) 1992-08-29 1994-03-03 Behringwerke Ag Verfahren zum Nachweis und zur Bestimmung von Mediatoren
GB9226065D0 (en) * 1992-12-14 1993-02-10 Ici Plc Peptides
AU6610194A (en) * 1993-07-01 1995-01-12 Cv Therapeutics, Inc. Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
AU7844894A (en) * 1993-09-27 1995-04-18 University Of Massachusetts Medical Center Receptor-activated reporter systems
WO1997033913A1 (en) * 1996-03-13 1997-09-18 Zymogenetics, Inc. Cytokine-receptor expressed in testis cells
DE19645729C1 (de) * 1996-11-06 1998-06-04 Brahms Diagnostica Gmbh Rezeptorbindungsassay, für den Rezeptorbindungsassay geeigneter rekombinanter Fusionsrezeptor, Vektor zu dessen Herstellung sowie Reagenziensatz für die Durchführung des Rezeptorbindungsassays
DE19651093C2 (de) * 1996-12-09 1999-06-10 Brahms Diagnostica Gmbh Rezeptorbindungsassay zum Nachweis von TSH-Rezeptor-Autoantikörpern sowie Reagenziensatz für die Durchführung eines solchen Rezeptorbindungsassays
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030022293A1 (en) * 1997-09-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2002017353A (ja) * 1997-12-19 2002-01-22 Japan Tobacco Inc 変性ｌｄｌの定量方法
US20030009013A1 (en) * 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1141711A1 (en) * 1999-01-05 2001-10-10 Unilever Plc Binding of antibody fragments to solid supports
JP4493125B2 (ja) * 1999-05-07 2010-06-30 独立行政法人理化学研究所 相互作用するタンパク質の検出方法
WO2001004292A1 (en) * 1999-07-13 2001-01-18 Merck Patent Gmbh G-protein coupled receptor and dna sequences thereof
US20020137209A1 (en) * 2000-06-13 2002-09-26 Stavroula Kousteni Methods of dissociating nongenotropic from genotropic activity of steroid receptors
EP1303539B1 (en) * 2000-07-26 2004-11-24 MERCK PATENT GmbH A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
US7442765B2 (en) * 2000-08-24 2008-10-28 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
US9249464B2 (en) 2004-11-29 2016-02-02 Sequenom, Inc. Kits and methods for detecting methylated DNA
JP5149013B2 (ja) 2004-11-29 2013-02-20 セクエノム，インコーポレイティド メチル化ｄｎａを検出する手段、及び方法
WO2015080513A1 (en) * 2013-11-29 2015-06-04 Hanwha Chemical Corporation A liquid formulation of a fusion protein comprising tnfr and fc region

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
ATE243754T1 (de) * 1987-05-21 2003-07-15 Micromet Ag Multifunktionelle proteine mit vorbestimmter zielsetzung
PT88641B (pt) * 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao
PT89484B (pt) * 1988-01-22 1994-03-31 Gen Hospital Corp Genes clonados codificadores de proteinas de fusao ig-cd4 e sua utilizacao
SE501169C2 (sv) * 1988-02-05 1994-11-28 Aake Nygren Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner
DE3806617A1 (de) * 1988-03-02 1989-09-14 Behringwerke Ag Erzeugung hochexprimierender, rekombinanter, eukaryotischer zellen
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
IL97996A0 (en) * 1990-04-30 1992-06-21 Novo Nordisk As Hybrid cellular receptor

Also Published As

Publication number Publication date
GR3020611T3 (en) 1996-10-31
EP0488170A1 (de) 1992-06-03
KR920009988A (ko) 1992-06-26
JPH06160395A (ja) 1994-06-07
DE59107974D1 (de) 1996-08-08
ATE140084T1 (de) 1996-07-15
PT99618B (pt) 1999-05-31
AU660950B2 (en) 1995-07-13
EP0488170B1 (de) 1996-07-03
JP3164865B2 (ja) 2001-05-14
DK0488170T3 (da) 1996-10-28
AU8814191A (en) 1992-06-04
KR100210183B1 (ko) 1999-07-15
CA2056279C (en) 2003-11-11
DE4037837A1 (de) 1992-06-04
CA2056279A1 (en) 1992-05-29
US5639597A (en) 1997-06-17
ES2090211T3 (es) 1996-10-16
IE914130A1 (en) 1992-06-03
IE75724B1 (en) 1997-09-24

Similar Documents

Publication Publication Date Title
PT99618A (pt) Processo para a realizacao de um ensaio de ligacao a recptores celulares isentode celulas e de identificacao caracterizacao e deteccao de agentes biologicos por meio desse ensaio
ATE276275T1 (de) Mhc-komplexe und ihre verwendungen
IL120082A0 (en) Method for determining the amount of an amylin receptor binding compound in a sample
ATE74663T1 (de) Quadratfarbstoffkonjugat, dessen herstellungsverfahren und dessen verwendung bei testverfahren sowie testsaetze.
PT89889A (pt) Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes
ATE317122T1 (de) Fluoreszierende polarisation
ATE113723T1 (de) Verfahren zur bestimmung von antikörpern.
ATE144838T1 (de) Heterogene immuntests
EA200000308A1 (ru) Способ и устройство для взятия биологических проб
DK0894498T3 (da) Fremgangsmåde til bestemmelse af kön af pattedyr-afkom
CA2000545A1 (en) Process and reagent for the determination of a specifically bindable substance
ATE208900T1 (de) Verringerung des hook-effekts in immuntests mit teilchenförmigem trägermaterial
DE3582643D1 (de) Testverfahren unter verwendung eines in eine zelle aufnehmbaren fluoreszierenden farbstoffs.
ES2090465T3 (es) Reactivo de dextrano multivalente para su empleo en ensayos por precipitacion.
NO20083610L (no) Cobalamin-maling
AU2375695A (en) Solid-phase filtration method for antigen and antibody assays in bloodgroup serology, and test kit
AU5601896A (en) Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses
ES2168310T3 (es) Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido.
DK0939810T3 (da) Transkriptionel intermediær faktor-2 TIF-2
DE3881223D1 (de) Mit der faehigkeit zur lokalisation von objekten ausgestattete liposomen und ihre verwendung in einem immunoassay.
AU1459392A (en) Method and apparatus for screening microscopic cells utilizing polarized light scatter techniques
Richards et al. Chemical Probes for the Geometry of Membrane Proteins

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920612

FG3A Patent granted, date of granting

Effective date: 19990202

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20140203